查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1978983

血液輸注設備市場：2026年至2032年全球市場預測，依產品、組件、方法、技術、應用、最終用戶及通路分類

Blood Transfusion Devices Market by Product, Component, Mode, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年，輸血設備市場價值為47.3億美元，預計到2026年將成長至51億美元，複合年成長率為7.63%，到2032年將達到79.3億美元。

主要市場統計數據
基準年 2025 47.3億美元
預計年份：2026年 51億美元
預測年份 2032 79.3億美元
複合年成長率 (%) 7.63%

輸血醫療設備領域瞬息萬變，正處於臨床需求、技術創新和嚴格監管三者交會的十字路口。自動化、數位化監控和材料科學的進步正在重塑血液的採集、處理、儲存和供應方式，而臨床醫生和管理人員則在尋求更安全、更有效率的工作流程。本報告整合了這些技術和營運趨勢，為讀者清楚闡述了整體市場趨勢以及影響近期市場應用和投資方向的關鍵因素。

本分析超越了簡單的產品目錄，著重於臨床效用、與臨床流程的整合以及對血液安全和供應鏈韌性的影響。因此，從製造商到醫院採購團隊等相關人員都能切實了解醫療設備的功能如何與臨床工作流程和監管要求相符。本引言概述了後續章節的框架，重點闡述了決策者在評估產品系列、夥伴關係和部署策略時應考慮的關鍵變革和實際挑戰。

自動化、數位整合、病人安全優先事項和採購經濟性如何同時重塑輸血醫療設備生態系統。

輸血設備領域正經歷著一場變革，其驅動力主要來自四大趨勢：自動化和精密工程、對病人安全和病原體控制的日益重視、設備數據與臨床資訊系統的數位整合，以及採購重點向總體擁有成本 (TCO) 和生命週期管理的轉變。自動化技術正從基礎機械化發展到基於複雜卡盒和盒式裝置的半自動化系統，甚至全機器人平台，從而實現更一致的處理流程並減少人為錯誤。同時，新型流量控制技術和感測器驅動的電子監視器正在提高劑量精度、最大限度地減少溶血並實現即時干預。

美國關稅的變化促使輸血醫療設備的相關人員在採購、近岸外包和供應鏈韌性方面做出策略性轉變。

美國近期關稅調整為依賴全球供應鏈獲取輸血設備及其組件的製造商、經銷商和臨床終端用戶帶來了新的挑戰。關稅變化影響了籌資策略，改變了進口耗材和設備的到貨成本，尤其是血袋、採血包以及用於血液成分分離和血液成分分離的一次性耗材等大批量耗材。因此，各機構正在重新評估供應商多元化以及國內生產的可行性，以降低關稅波動和運輸中斷帶來的風險。

透過明確的綜合細分，揭示產品類型、臨床應用、最終用戶、組件、運輸方式、分銷管道和技術如何相互交織並影響設備選擇。

這種細分揭示了臨床需求、操作限制和採購偏好如何微妙地影響輸血醫療設備領域的產品開發和商業化策略。考慮到產品的多樣性，所提供的產品範圍從單針和雙針配置的複雜血漿分離系統到單袋或多袋血袋。血液採集套裝設計為封閉式系統以最大限度降低污染風險，或設計為開放式系統以適應低成本的血液採集場景。成分分離器提供自動和手動兩種類型，以滿足不同的處理能力需求。白血球去除過濾器可用於床邊或預儲存處理，並根據臨床時間和物流需求進行客製化。輸血幫浦進一步分為用於精確小劑量輸注的注射器式輸血幫浦和用於滿足持續輸注需求的容積式輸血幫浦。這些產品層面的選擇直接影響採購規範和臨床工作流程。

美洲、歐洲、中東和非洲以及亞太地區的趨勢和採用模式存在區域差異，這影響產品策略和監管方法。

區域趨勢對整個輸血器材產業的臨床實務、採購行為、監管預期和創新應用都具有顯著影響。在美洲，先進的臨床基礎設施和集中化的研究生態系統正在加速自動化和電子流量控制技術的應用。同時，集中化的報銷機制和大規模醫院系統也催生了對擴充性解決方案和完善的售後支援的需求。另一方面，由於跨司法管轄區的監管協調、多樣化的醫院資金籌措機制以及不同的捐血應用呈現出複雜多樣的格局，既有先進技術的應用，也有資源適應性較強的應用。

競爭考察和策略定位洞察揭示了創新、夥伴關係和服務卓越如何決定輸血設備市場的領導地位。

輸血設備市場的競爭動態由產品創新、服務模式、監管專業知識和夥伴關係生態系統決定。主要企業傾向於透過投資自動化、感測器驅動的監測以及耗材設計來尋求差異化，從而減少操作人員的差異並提高病患安全。同時，新興醫療技術公司和專業契約製造正在推出各種利基創新產品，以填補現有市場在價格和易用性方面的空白，例如符合人體工學設計的血液分離模組和低成本的過濾耗材。

針對領導者的具體建議，重點在於互通性、供應鏈韌性、卓越服務以及符合臨床醫生需求的產品設計。

產業領導企業可以透過以下方式將洞察轉化為競爭優勢：使產品藍圖與臨床工作流程保持一致，優先考慮互通性，並投資於供應鏈韌性。首先，醫療設備開發商應整合感測器和微處理器控制，以增強安全功能並實現數據驅動的維護。同時，他們需要確保與電子健康記錄和輸血管理系統的互通性，以簡化臨床醫生的工作流程。其次，製造商應尋求靈活的生產結構和區域夥伴關係，以降低關稅風險並縮短前置作業時間。這將有助於實現具有競爭力的價格和可靠的服務交付。

採用穩健的混合研究途徑，整合監管審查、技術檢驗和臨床醫生見解，以確保設備智慧的可靠性。

本調查方法結合了對公開監管文件、技術標準和同行評審臨床文獻的系統性回顧，以及對臨床醫生、採購負責人和醫療設備工程師的初步定性訪談。數據透過供應商文件、技術白皮書和觀察到的臨床通訊協定檢驗三角驗證，以檢驗功能聲明並識別新的使用模式。透過對醫療設備功能、培訓要求和上市後支援模式進行交叉檢驗，確保了分析的嚴謹性，同時考慮了區域監管路徑，以評估推廣應用的促進因素和障礙。

結論強調，最佳化輸血實務需要結合創新、臨床協調和供應鏈前瞻性的整合策略。

總之，輸血設備產業正日益成熟，發展成為一個更複雜的生態系統，設備自動化、數位化控制和供應鏈策略是臨床和商業性成功的關鍵。諸如白血球去除、精確的血液成分分離和安全輸血等臨床需求，正在推動產品需求和服務期望的差異化。同時，關稅波動和地區法規差異等外部壓力，迫使製造商和醫療系統更加謹慎地考慮採購、本地化和全生命週期支援。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 輸血設備市場：依產品分類

  • 血液分離系統
    • 雙針
    • 單針
  • 血袋
    • 多口袋
    • 單口袋
  • 採血工具包
    • 封閉式系統
    • 開放系統
  • 組件分離裝置
    • 自動分離裝置
    • 手動分離裝置
  • 白血球去除過濾器
    • 床頭
    • 保存前
  • 輸血泵
    • 注射器
    • 正位移

第9章 輸血設備市場：依組件分類

  • 電漿
    • 冷凍機配方
    • 新鮮冷凍血漿
  • 血小板
    • 血小板分離術（血小板分離術）
    • 混合血小板
  • 紅血球
  • 白血球
    • 粒細胞濃縮液
    • 淋巴球濃縮液

第10章：依方法分類的輸血設備市場

  • 自動的
    • 全自動桌面打字
    • 機器人系統
  • 手動的
  • 半自動
    • 墨水匣類型
    • 盒式

第11章 輸血設備市場：依技術分類

  • 傳統流量控制
    • 重力型
    • 加壓輸液
  • 電子流量控制
    • 微處理器系統
    • 感測器類型

第12章 輸血設備市場：依應用領域分類

  • 血液分離術
    • 血液採集的分離術
    • 治療性血液分離術
  • 血液樣本
    • 血液分離術
    • 全血採集
  • 組分分離
    • 離心分離法
    • 過濾類型
  • 白血球去除
    • 離心分離法
    • 過濾類型
  • 輸血
    • 持續輸血
    • 間歇性輸血

第13章 輸血設備市場：依最終用戶分類

  • 血庫和捐血中心
    • 公立醫療機構
    • 私立醫療機構
  • 醫院
    • 私立醫院
    • 公立醫院

第14章 輸血設備市場：依通路分類

  • 直銷
  • 醫院藥房
    • 集中式管理類型
    • 在醫院裡
  • 線上銷售
    • B2B平台
    • 製造商網站
  • 零售藥房

第15章 輸血設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 輸血設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 輸血設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國輸血設備市場

第19章：中國輸血器材市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Cerus Corporation
  • Fresenius Kabi AG
  • Grifols, SA
  • Haemonetics Corporation
  • Immucor, Inc.
  • Jiangsu Kangjin Medical Instrument Co.,Ltd.
  • Macopharma SA
  • Nipro Medical Corporation
  • Sarstedt AG & Co. KG
  • Siemens AG
  • SURU INTERNATIONAL PVT. LTD.
  • Terumo Corporation
Product Code: MRR-521BAA36EADD

The Blood Transfusion Devices Market was valued at USD 4.73 billion in 2025 and is projected to grow to USD 5.10 billion in 2026, with a CAGR of 7.63%, reaching USD 7.93 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.73 billion
Estimated Year [2026] USD 5.10 billion
Forecast Year [2032] USD 7.93 billion
CAGR (%) 7.63%

The evolving field of blood transfusion devices is at the intersection of clinical necessity, engineering innovation, and regulatory rigor. Advances in device automation, digital monitoring, and materials science are reshaping how blood is collected, processed, stored, and delivered, while clinicians and administrators seek safer, more efficient workflows. This report synthesizes these technological and operational trends to give readers a clear orientation of the landscape and the forces that will shape adoption and investment trajectories in the near term.

Rather than focusing solely on product catalogs, the analysis emphasizes clinical utility, integration into care pathways, and the implications for blood safety and supply chain resilience. Consequently, stakeholders from manufacturers to hospital procurement teams will gain a practical understanding of how device capabilities intersect with clinical workflows and regulatory expectations. This introduction frames the subsequent sections by highlighting pivotal transitions and the practical considerations that decision-makers should weigh when evaluating product portfolios, partnerships, and deployment strategies.

How automation, digital integration, patient safety priorities, and procurement economics are simultaneously reshaping the blood transfusion device ecosystem

The blood transfusion device landscape is experiencing transformative shifts driven by four converging trends: automation and precision engineering, intensified focus on patient safety and pathogen mitigation, digital integration of device data into clinical information systems, and evolving procurement priorities that emphasize total cost of ownership and lifecycle management. Automation has progressed from basic mechanization to sophisticated cartridge- and cassette-based semi-automated systems as well as fully robotic platforms, enabling more consistent processing and reduced human error. In parallel, emerging flow control technologies and sensor-driven electronic monitors are improving dose accuracy, minimizing hemolysis, and enabling real-time intervention.

Moreover, heightened awareness of transfusion-transmitted infections and the demand for component-specific therapies have prioritized leukocyte reduction, component separation, and pathogen reduction strategies. These clinical drivers have prompted manufacturers to innovate filtration and centrifugal systems as well as bedside devices that integrate seamlessly with hospital workflows. At the same time, procurement decision-making is shifting toward solutions that offer interoperability, remote diagnostics, and predictable maintenance pathways. Taken together, these shifts are catalyzing product refinements and commercial models that better address clinical and operational imperatives, thereby redefining competitive differentiation within the sector.

Tariff changes in the United States prompting strategic shifts in sourcing, nearshoring, and supply chain resilience for blood transfusion device stakeholders

Recent tariff adjustments in the United States have introduced new complexities for manufacturers, distributors, and clinical end users that rely on global supply chains for blood transfusion devices and components. Tariff changes influence sourcing strategies by altering landed costs for imported consumables and equipment, particularly for high-volume items such as blood bags, collection sets, and disposables used in apheresis and component separation. As a result, organizations are reassessing supplier diversification and onshore manufacturing viability to mitigate exposure to tariff volatility and shipping disruptions.

In response, many firms are evaluating nearshoring and regional manufacturing partnerships to preserve margin and maintain timely supply, while others are adjusting pricing and contract terms to account for the potential pass-through of duties. Simultaneously, procurement teams within blood banks and hospitals are increasingly demanding clearer cost transparency, longer-term supply agreements, and contingency plans that address customs complexity and compliance. These reactions collectively shift investment toward supply chain resilience measures, including local inventory buffers, multi-sourcing strategies, and closer collaboration with logistics partners to manage tariff-induced cost variability and operational risk.

Comprehensive segmentation clarity revealing how product types, clinical applications, end users, components, modes, distribution channels, and technologies intersect to drive device selection

Segmentation reveals the nuanced ways clinical requirements, operational constraints, and procurement preferences shape product development and commercialization tactics within the blood transfusion device arena. When product distinctions are considered, offerings range from complex apheresis systems-available in single needle and double needle configurations-to blood bags that come as single pocket or multi pocket formats; blood collection sets are engineered as closed systems to minimize contamination risk or open systems for lower-cost collection scenarios; component separators appear as automated and manual units to serve different throughput needs; leukocyte reduction filters are positioned for bedside application or pre-storage processing to match clinical timing and logistics; and transfusion pumps are split between syringe-based devices for small-volume precision and volumetric pumps for continuous infusion demands. These product-level choices directly affect procurement specifications and clinical workflows.

Application-based segmentation further clarifies usage patterns, extending from collection-focused apheresis-distinguished between collection apheresis procedures and therapeutic apheresis interventions-to blood collection workflows that include dedicated apheresis collection and whole blood collection approaches. Component separation is executed through centrifugation-based or filtration-based methods, and leukocyte reduction can employ either centrifugation or filtration mechanisms depending on throughput and clinical objectives. Transfusion procedures themselves are characterized by continuous transfusion modalities versus intermittent transfusion episodes, impacting device selection and monitoring protocols.

End user distinctions also guide product positioning and service models, with blood banks and donation centers-operating in government-run or private configurations-demanding high-throughput, durable systems and predictable consumable supply, while hospitals, whether private or public, require devices that integrate into patient care pathways and accommodate varied staffing competencies. Component-wise segmentation recognizes the different handling and storage needs for plasma, platelets, red blood cells, and white blood cells; plasma subtypes include cryoprecipitate and fresh frozen plasma, platelets are sourced as apheresis platelets or pooled platelets, and white blood cells are categorized into granulocyte concentrates and lymphocyte concentrates, each presenting specific processing and quality control requirements.

Mode and distribution channel segmentation further influence adoption patterns; automated, manual, and semi-automated modes-where automated offerings range from fully automated desktop units to robotic systems and semi-automated devices use cartridge- or cassette-based designs-determine capital intensity and training needs, while distribution channels such as direct sales, hospital pharmacies (centralized or in-house), online sales through B2B platforms or manufacturer websites, and retail pharmacies shape accessibility, procurement friction, and service expectations. Finally, technology choices between conventional flow control methods, including gravity-fed and pressure infusion approaches, and electronic flow control solutions that are microprocessor-based or sensor-driven create distinct value propositions related to safety, traceability, and integration with clinical information systems. Understanding these interconnected segmentation axes enables stakeholders to refine product roadmaps, target the right end users, and design service models that align with clinical and operational realities.

Regional dynamics and differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping product strategies and regulatory approaches

Regional dynamics exert substantial influence on clinical practice, procurement behavior, regulatory expectations, and innovation diffusion across the blood transfusion device sector. In the Americas, advanced clinical infrastructures and concentrated research ecosystems accelerate adoption of automated and electronic flow control technologies, while concentrated reimbursement frameworks and large hospital systems create demand for scalable solutions and robust post-market support. Conversely, the Europe, Middle East & Africa region presents a heterogeneous landscape in which regulatory alignment across jurisdictions, variable hospital funding mechanisms, and differing blood donation systems lead to a mix of advanced and resource-adapted device deployments.

In Asia-Pacific, rapid healthcare infrastructure expansion, growing blood service modernization efforts, and a strong manufacturing base combine to drive both domestic innovation and export-oriented production. Transitional economies within the region are investing in semi-automated and modular systems that can be integrated incrementally, whereas high-income markets prioritize full automation and seamless digital interoperability. Across all regions, local regulatory nuances, workforce capabilities, and supply chain logistics influence device specification decisions and the pace of clinical acceptance. Consequently, manufacturers and distributors must adopt regionally tailored strategies that address funding models, regulatory timelines, training requirements, and spare parts logistics to ensure sustained adoption and operational success.

Competitive realities and strategic positioning insights that reveal how innovation, partnerships, and service excellence determine leadership in transfusion device markets

Competitive dynamics in the blood transfusion device landscape are defined by product innovation, service models, regulatory expertise, and partnership ecosystems. Leading companies tend to differentiate through investments in automation, sensor-enabled monitoring, and consumable design that reduce operator variability and improve patient safety. At the same time, emerging medtech entrants and specialized contract manufacturers are introducing niche innovations, from ergonomic apheresis modules to low-cost filtration consumables, that target gaps in affordability and usability.

Strategic partnerships between device manufacturers and clinical networks are increasingly common, enabling iterative product validation, real-world performance feedback, and faster adoption cycles. Companies that establish robust post-market surveillance, remote diagnostics, and training programs strengthen customer relationships and reduce lifecycle costs for end users. Furthermore, firms that invest in scalable manufacturing footprints and diversified distribution channels are better positioned to respond to tariff fluctuations and supply chain shocks. Ultimately, competitive advantage accrues to organizations that couple regulatory competence with modular product architectures and service offerings tailored to both high-resource and resource-constrained environments.

Actionable recommendations for leaders focusing on interoperability, supply chain resilience, service excellence, and clinician-aligned product design

Industry leaders can take concrete actions to convert insight into advantage by aligning product roadmaps with clinical workflows, prioritizing interoperability, and investing in supply chain resilience. First, device developers should embed sensors and microprocessor controls to enhance safety features and enable data-driven maintenance, while ensuring interoperability with electronic health records and transfusion management systems to streamline clinician workflows. Secondly, manufacturers should pursue flexible manufacturing and regional partnerships to reduce tariff exposure and shorten lead times, enabling competitive pricing and reliable service delivery.

Additionally, organizations should expand their service propositions beyond warranty and repair to include training curricula, remote diagnostics, and consumable management programs that lower total cost of ownership for buyers. Collaborations with clinical centers for real-world evidence generation will accelerate credibility and support reimbursement discussions. Finally, procurement and clinical leaders within hospitals and blood centers should adopt multi-vendor engagement strategies and standardized specifications that emphasize compatibility, training support, and predictable supply arrangements; these measures will mitigate operational risk and improve long-term value realization.

Robust mixed-methods research approach integrating regulatory review, technical validation, and clinician insights to ensure credible device intelligence

The research methodology combined a systematic review of publicly available regulatory documents, technical standards, and peer-reviewed clinical literature with primary qualitative interviews of clinicians, procurement professionals, and device engineers. Data was triangulated using supplier documentation, technical white papers, and observed clinical protocols to validate feature claims and identify emergent usage patterns. Analytical rigor was applied through cross-validation of device functionality, training requirements, and post-market support models, while attention to regional regulatory pathways informed assessments of adoption enablers and barriers.

Where possible, insights were corroborated through multiple independent sources and clinical end-user perspectives to ensure that assertions about device utility and operational fit reflect real-world workflows. Limitations of the methodology include variability in publicly disclosed performance data and the proprietary nature of some post-market outcomes, which were mitigated through targeted expert consultations. This mixed-methods approach yields actionable intelligence designed to inform strategic decisions without relying on proprietary market sizing or forecasting estimates.

Concluding synthesis emphasizing the necessity of integrated strategies that combine innovation, clinical alignment, and supply chain foresight to optimize transfusion practices

In conclusion, the blood transfusion device sector is maturing into a more sophisticated ecosystem where device automation, digital control, and supply chain strategy determine clinical and commercial success. Clinical imperatives such as leukocyte reduction, precise component separation, and safe transfusion delivery are driving differentiated product requirements and service expectations. Meanwhile, external pressures including tariff variability and regional regulatory diversity compel manufacturers and health systems to be more deliberate about sourcing, localization, and lifecycle support.

Moving forward, organizations that align product development with clinical workflows, invest in interoperable and sensor-driven technologies, and adopt resilient manufacturing and distribution strategies will be better positioned to meet both patient safety objectives and institutional procurement priorities. This conclusion underscores the importance of integrated strategies that combine technical innovation, operational foresight, and strong clinical collaborations to realize the full potential of modern transfusion device technology.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Transfusion Devices Market, by Product

  • 8.1. Apheresis System
    • 8.1.1. Double Needle
    • 8.1.2. Single Needle
  • 8.2. Blood Bag
    • 8.2.1. Multi Pocket
    • 8.2.2. Single Pocket
  • 8.3. Blood Collection Set
    • 8.3.1. Closed System
    • 8.3.2. Open System
  • 8.4. Component Separator
    • 8.4.1. Automated Separator
    • 8.4.2. Manual Separator
  • 8.5. Leukocyte Reduction Filter
    • 8.5.1. Bedside
    • 8.5.2. Pre Storage
  • 8.6. Transfusion Pump
    • 8.6.1. Syringe
    • 8.6.2. Volumetric

9. Blood Transfusion Devices Market, by Component

  • 9.1. Plasma
    • 9.1.1. Cryoprecipitate
    • 9.1.2. Fresh Frozen Plasma
  • 9.2. Platelets
    • 9.2.1. Apheresis Platelets
    • 9.2.2. Pooled Platelets
  • 9.3. Red Blood Cells
  • 9.4. White Blood Cells
    • 9.4.1. Granulocyte Concentrates
    • 9.4.2. Lymphocyte Concentrates

10. Blood Transfusion Devices Market, by Mode

  • 10.1. Automated
    • 10.1.1. Fully Automated Desktop
    • 10.1.2. Robotic Systems
  • 10.2. Manual
  • 10.3. Semi Automated
    • 10.3.1. Cartridge Based
    • 10.3.2. Cassette Based

11. Blood Transfusion Devices Market, by Technology

  • 11.1. Conventional Flow Control
    • 11.1.1. Gravity Fed
    • 11.1.2. Pressure Infusion
  • 11.2. Electronic Flow Control
    • 11.2.1. Microprocessor Based
    • 11.2.2. Sensor Based

12. Blood Transfusion Devices Market, by Application

  • 12.1. Apheresis
    • 12.1.1. Collection Apheresis
    • 12.1.2. Therapeutic Apheresis
  • 12.2. Blood Collection
    • 12.2.1. Apheresis Collection
    • 12.2.2. Whole Blood Collection
  • 12.3. Component Separation
    • 12.3.1. Centrifugation Based
    • 12.3.2. Filtration Based
  • 12.4. Leukocyte Reduction
    • 12.4.1. Centrifugation Based
    • 12.4.2. Filtration Based
  • 12.5. Transfusion
    • 12.5.1. Continuous Transfusion
    • 12.5.2. Intermittent Transfusion

13. Blood Transfusion Devices Market, by End User

  • 13.1. Blood Banks & Donation Centers
    • 13.1.1. Government Centers
    • 13.1.2. Private Centers
  • 13.2. Hospitals
    • 13.2.1. Private Hospitals
    • 13.2.2. Public Hospitals

14. Blood Transfusion Devices Market, by Distribution Channel

  • 14.1. Direct Sales
  • 14.2. Hospital Pharmacies
    • 14.2.1. Centralized
    • 14.2.2. In House
  • 14.3. Online Sales
    • 14.3.1. B2B Platforms
    • 14.3.2. Manufacturer Websites
  • 14.4. Retail Pharmacies

15. Blood Transfusion Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Blood Transfusion Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Blood Transfusion Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Blood Transfusion Devices Market

19. China Blood Transfusion Devices Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. B. Braun Melsungen AG
  • 20.6. Baxter International Inc.
  • 20.7. Becton, Dickinson and Company
  • 20.8. bioMerieux SA
  • 20.9. Cerus Corporation
  • 20.10. Fresenius Kabi AG
  • 20.11. Grifols, S.A.
  • 20.12. Haemonetics Corporation
  • 20.13. Immucor, Inc.
  • 20.14. Jiangsu Kangjin Medical Instrument Co.,Ltd.
  • 20.15. Macopharma SA
  • 20.16. Nipro Medical Corporation
  • 20.17. Sarstedt AG & Co. KG
  • 20.18. Siemens AG
  • 20.19. SURU INTERNATIONAL PVT. LTD.
  • 20.20. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY POOLED PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY POOLED PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY POOLED PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GRANULOCYTE CONCENTRATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GRANULOCYTE CONCENTRATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GRANULOCYTE CONCENTRATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LYMPHOCYTE CONCENTRATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LYMPHOCYTE CONCENTRATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LYMPHOCYTE CONCENTRATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FULLY AUTOMATED DESKTOP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FULLY AUTOMATED DESKTOP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FULLY AUTOMATED DESKTOP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CARTRIDGE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CARTRIDGE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CARTRIDGE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CASSETTE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CASSETTE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CASSETTE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GRAVITY FED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GRAVITY FED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GRAVITY FED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRESSURE INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRESSURE INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRESSURE INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MICROPROCESSOR BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MICROPROCESSOR BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MICROPROCESSOR BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SENSOR BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SENSOR BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SENSOR BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRALIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRALIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRALIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY IN HOUSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY IN HOUSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY IN HOUSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY B2B PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY B2B PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY B2B PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 242. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 243. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 244. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 245. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2032 (USD MILLION)
  • TABLE 246. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2032 (USD MILLION)
  • TABLE 247. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2032 (USD MILLION)
  • TABLE 248. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2032 (USD MILLION)
  • TABLE 249. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2032 (USD MILLION)
  • TABLE 250. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 251. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 252. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 253. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 254. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 255. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 256. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 257. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, 2018-2032 (USD MILLION)
  • TABLE 259. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, 2018-2032 (USD MILLION)
  • TABLE 260. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2032 (USD MILLION)
  • TABLE 262. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 263. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 264. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2032 (USD MILLION)
  • TABLE 265. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 266. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2032 (USD MILLION)
  • TABLE 268. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 269. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 271. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 272. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 274. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2032 (USD MILLION)
  • TABLE 276. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2032 (USD MILLION)
  • TABLE 278. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2032 (USD MILLION)
  • TABLE 280. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 282. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 284. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 286. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, 2018-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, 2018-2032 (USD MILLION)
  • TABLE 290. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2032 (USD MILLION)
  • TABLE 292. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 294. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 296. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2032 (USD MILLION)
  • TABLE 298. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TA